Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Recalcitrant Cutaneous Dermatomyositis
NCT03529955Phase 2Completed
- Sponsor
- Tulane University
- Start
- Jun 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in dermatomyositis (DM), sponsored by Tulane University. Started Jun 2018; status: completed.
02
Drugs
apremilast
03
Conditions
dermatomyositis (DM)
Beyond the preview
Go deeper on NCT03529955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529955.